Strategies to prevent kidney injury from antibiotics in people with cystic fibrosis
Cochrane Database of Systematic Reviews, ISSN: 1469-493X, Vol: 2018, Issue: 5
2018
- 3Citations
- 19Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of strategies (such as altering the type and dose of intravenous antibiotics, the avoidance of other nephrotoxic drugs alongside the intravenous antibiotics and the use of adjuvant medication including statins and fluids) to reduce or prevent kidney damage in people with CF which occurs as a results of intravenous antibiotic treatment.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know